Company / Operating Margin
GYRE THERAPEUTICS, INC. Operating Margin History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
9.8%
FY2025
5-year range
-1197.8% / 15.3%
FY2021-FY2025
Trend
-35.5%
vs FY2024
Sector context
#43 of 135
Health Care
What the data says
At 9.8%, GYRE THERAPEUTICS, INC.'s operating margin ranks #43 of 135 in the Health Care sector. Operating Margin has fluctuated over the past 7 years, ranging from -2143.6% in FY2018 to 15.3% in FY2024.
Based on SEC 10-K filings.
9.8% in FY2025 with a 5-year CAGR of +283.3%.
Improved from 9.0% to 9.8% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- +0.9pp
- 5-Year Change
- +283.3pp
- 10-Year Change
- -
Sector benchmark
#43 of 135 in Health CareTop 32% of 135This company 9.8% Sector average -774.4%
▼
+101.3% above sector average
Key checks
Key Insights
- In FY2025, operating margin decreased 35.5% year-over-year.
- Currently 784.3pp above the Health Care sector average.
- Peak operating margin was recorded in FY2024.
- Lowest operating margin in the period was in FY2018.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 9.8% | -35.5% |
| FY2024 | 15.3% | +69.8% |
| FY2023 | 9.0% | +0.0% |
| FY2022 | 9.0% | +100.8% |
| FY2021 | -1197.8% | -338.1% |
| FY2020 | -273.4% | - |
| FY2019 | - | - |
| FY2018 | -2143.6% | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026